What is the issue price of Mankind Pharma IPO?

Mankind Pharma IPO issue price band is ₹1,026-1,080 per share with a lot size of 13 Shares.

When is Mankind Pharma IPO listing date?

Mankind Pharma IPO listed on May 9, 2024 at ₹1,300.

Mankind Pharma IPO GMP Today Live ₹250 | Allotment Status & Subscription

Q: How to check Mankind Pharma IPO allotment status?

You can check Mankind Pharma IPO allotment status on the registrar (Link Intime) website using your PAN or application number.

Q: What is Mankind Pharma IPO subscription status?

Mankind Pharma IPO subscription: QIB 55.7x, NII 27.1x, Retail 14.5x.

Live Grey Market Premium+₹250

Expected Listing₹1330

Expected Gain+23.15%

Subscription Status

QIB55.7x

NII / HNI27.1x

Retail14.5x

Listing Performance

Issue Price₹1,026-1,080

Listing Price₹1,300

Mankind Pharma: Detailed Financial Analysis

## Mankind Pharma IPO: Comprehensive Financial Analysis Mankind Pharma launched its Initial Public Offering (IPO) with a total issue size of ₹4,326 Cr, offering shares in the price band of ₹1,026-1,080 per share with a minimum lot size of 13 Shares. The IPO opened for subscription on Apr 25, 2024 and closed on Apr 27, 2024. The stock listed at ₹1,300 against an issue price of ₹1,026-1,080, delivering significant listing gains to investors. ### Grey Market Premium (GMP) Analysis The current Grey Market Premium (GMP) for Mankind Pharma stands at ₹250 per share, indicating positive market sentiment and strong demand in the unofficial grey market. A positive GMP suggests that investors expect the stock to list above its issue price, which is a bullish indicator for potential listing gains. ### Subscription Status The institutional response to Mankind Pharma IPO has been noteworthy. The Qualified Institutional Buyers (QIB) category was subscribed 55.7x. Non-Institutional Investors (NII) showed 27.1x subscription, while the Retail Individual Investor (RII) category recorded 14.5x subscription. ### Investment Considerations Investors evaluating Mankind Pharma should consider several key factors. The company operates in a established market segment with strong revenue growth trajectory and improving profit margins. The issue price valuation at ₹1,026-1,080 per share positions the company at a reasonable valuation compared to listed industry peers. Key risk factors include market volatility, regulatory changes, and sector-specific headwinds that could impact post-listing performance. Investors should carefully review the Draft Red Herring Prospectus (DRHP) filed with SEBI for complete financial disclosures, including revenue trends, profitability metrics, debt-to-equity ratios, and management discussion on future growth strategies. ### Allotment and Listing Timeline The allotment for Mankind Pharma IPO has been finalized. Investors can check their allotment status through the registrar Link Intime's website. The stock is now listed and trading on BSE and NSE. ### Market Outlook Given the strong subscription numbers and positive GMP, Mankind Pharma appears well-positioned for a favorable listing. The robust institutional demand particularly from QIBs validates the company's business model and growth prospects. However, investors should maintain realistic return expectations and consider holding for medium to long-term value creation rather than purely speculative listing gains. *Disclaimer: Grey Market Premium data is sourced from unofficial market channels and should not be considered investment advice. Past GMP trends do not guarantee future listing performance. Investors should conduct their own due diligence and consult SEBI-registered investment advisors before making investment decisions.*

Frequently Asked Questions

What is Mankind Pharma IPO GMP today?▼

The current Grey Market Premium for Mankind Pharma IPO is ₹250. This positive GMP indicates strong market demand.

How to check Mankind Pharma IPO allotment status?▼

Visit the registrar (Link Intime) website and enter your PAN or application number. You can also check on BSE's allotment status page.

What is Mankind Pharma IPO subscription status?▼

QIB category: 55.7x, NII/HNI category: 27.1x, Retail category: 14.5x.

Should I invest in Mankind Pharma IPO?▼

Investment decisions should be based on thorough research of the company's financials, growth prospects, and risk factors outlined in the DRHP. Consult a SEBI-registered advisor.

What is the lot size and price band of Mankind Pharma IPO?▼

The minimum lot size is 13 Shares with a price band of ₹1,026-1,080. Total minimum investment required is approximately the lot size multiplied by the upper price band.

Mankind Pharma IPO

Subscription Status

Listing Performance

Check Mankind Pharma Allotment Status

Mankind Pharma: Detailed Financial Analysis

Frequently Asked Questions

Related 2024 IPOs

Tata Technologies

IREDA

Cello World

Mama Earth (Honasa Consumer)

JSW Infrastructure

Signature Global